Mirus Bio的封面图片
Mirus Bio

Mirus Bio

生物技术研究

Madison,WI 4,959 位关注者

The Transfection Experts

关于我们

OUR MISSION: Deliver Innovation. Empower Discovery. Improve Life. For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and partners to achieve strong results. Mirus, together with MilliporeSigma, the life science arm of Merck KGaA, Darmstadt, Germany, is establishing the future of science and medicine by developing products that enable product developers within the cell and gene therapy space. As we approach a new era of addressing and conquering life-altering diseases, we will continue to expand our expertise and leadership in transfection to be integral in the future of advanced therapies.

网站
https://www.mirusbio.com
所属行业
生物技术研究
规模
51-200 人
总部
Madison,WI
类型
上市公司
创立
1994
领域
Upstream Process Development、Viral Vector Transfection、Transfection和Cell & Gene Therapy

地点

  • 主要

    5602 Research Park Blvd

    Ste 210

    US,WI,Madison,53719

    获取路线

Mirus Bio员工

动态

  • 查看Mirus Bio的组织主页

    4,959 位关注者

    Live from Bioprocessing Summit Europe! If you're in Barcelona, don't miss Hayder Abdul-Razak, our Field Application Scientist, presenting at the Merck Life Science booth! He’s sharing the latest innovations in #transfection and #upstream processing - helping #bioprocessing teams optimize viral vector production. ?? Where to find us:? Booth 27 – Meet us at booth?27 Poster B23 – Learn about our newest advancements in AAV manufacturing Stop by, ask questions, and see how our upstream solutions can support your bioprocessing needs!? Check out the poster later this week here: https://lnkd.in/e6GAkc5F

    • Bioprocessing Summit Europe 2025. See Merck KGaA, Darmstadt, Germany and Mirus Bio in booth 27 or at poster B23 in Barcelona, Spain.
The poster is titled: Achieve Higher AAV Productivity with The Next-Generation Transfection Reagent TransIT?-AAViator
  • 查看Mirus Bio的组织主页

    4,959 位关注者

    We're Hiring! Join Mirus Bio as a Customer Service Associate Mirus Bio is looking for a Customer Service Associate to support our customers and ensure seamless order processing. If you have a keen eye for detail and a passion for customer service, this could be the role for you! Your Impact:? ?? Process domestic & international orders (phone, email, web, EDI)? ?? Assist customers with inquiries & order clarifications? ?? Generate invoices, track shipments, & maintain accurate records? ?? Work with cross-functional teams to support daily operations Get the full details in the link below! https://lnkd.in/e9AXqavT

    • Join our team at Mirus Bio as a Customer Service Associate in Madison, Wisconsin
  • 查看Mirus Bio的组织主页

    4,959 位关注者

    Does your AAV production feel like a Hollywood production?? Coming to Mirus+ this March: These might not have been featured at last night’s Oscars, but the must-watch events of the season are already available on our site. Watch the latest webinar from transfection experts Sandy Tseng and Hugh Murray (MilliporeSigma). Audiences raved last week about solutions to scaling AAV, including a "behind-the-scenes" look at case study that scaled to a 200 liter bioreactor. Swipe through the “app” to see more about the latest webinars to support your upstream demand. Then click play: https://lnkd.in/d-6Spdya

  • 查看Mirus Bio的组织主页

    4,959 位关注者

    Lost yield when scaling past shake flasks? Learn how to maintain titers at 200L and beyond. Scaling AAV production requires more than just larger equipment - it demands a deep understanding of process development. Join Sandy Tseng (Mirus Bio) and Hugh Murray (MilliporeSigma) today as they share a real-world case study on #AAV process optimization and transfection efficiency in large bioreactors. Don’t miss this opportunity to level up your #bioprocessing knowledge. ?? ? Register now before it’s too late! https://lnkd.in/gqUg9xdH

    • Starting in 2 hours: avoiding scale-up pitfalls: upstream process development strategies for AAV manufacturing.
30 minutes plus question and answer period.
February 26th at 11 EST
  • 查看Mirus Bio的组织主页

    4,959 位关注者

    Two can't-miss events this week for upstream process developers! Mirus Bio’s #transfection experts are hitting the virtual stage to help you optimize #AAV production with next-gen transfection solutions. Whether you're looking to streamline scale-up or explore cutting-edge reagents, these sessions will give you the insights you need. ?? Tuesday, Feb 25 | 10 AM ET – Bioprocess Online: Bio-Expo Live? Learn about the latest innovations in transfection technology for viral vector manufacturing. ?? Wednesday, Feb 26 | 11 AM ET – Cell & Gene Therapy Insights Webinar? Avoid scale-up pitfalls & optimize AAV production with real-world strategies from a 200L bioreactor case study.? Don’t miss your chance to get expert guidance on tackling upstream challenges. Register now! ?? https://lnkd.in/eWyuDvFh

    • This week: upstream processing events

Monday - continue aav troubleshooting
Tuesday - learn about next-gen transfection reagents (live webinar)
Wednesday - watch aav scaling webinar (live webinar)
Thursday - connect with a transfection expert at Mirus Bio
  • 查看Mirus Bio的组织主页

    4,959 位关注者

    AAV manufacturing has long struggled with low yields at large scales. How do you ensure a successful transition from shake flasks to hundreds of liters without compromising titer or percent full capsids? Join our upcoming Cell & Gene Therapy Insights webinar where Sandy Tseng (Mirus Bio) and Hugh Murray (MilliporeSigma) will break down:? ?? Plasmid ratio optimization for higher yields? ?? How small-scale experiments translate to bioreactor success? ?? The impact of [ht]transfection reagent selection on scalability If you're working in #CellAndGeneTherapy manufacturing, this session is for you.? ?? Save your spot: https://lnkd.in/e8xXAbGu

    • Having trouble scaling-up?
Gain insights from a case study on upstream process development for successful AAV production in a 200L bioreactor
  • 查看Mirus Bio的组织主页

    4,959 位关注者

    We’re #Hiring! Two exciting opportunities at Mirus Bio! Mirus Bio is expanding, and we’re looking for passionate experts to join our team! We currently have two key openings: ?? Field Application Scientist (Schwalbach, Hessen, Germany) Help scientists optimize #transfection, electroporation, and viral vector workflows by providing technical field support, training, and product demonstrations. If you have strong lab experience, customer engagement skills, and a passion for cell and gene therapy, this role is for you! ?? Field Regulatory Specialist (Madison, WI) Guide customers through FDA IND filings, risk assessments, and compliance for using transfection reagents in CGT manufacturing. If you have 5+ years in regulatory affairs and expertise in FDA/EMA guidelines, this is your opportunity to make an impact! Join us in driving the future of #CellAndGeneTherapy innovation! Apply now: https://lnkd.in/e2fyHDVE #BiotechJobs #LifeSciences

    • 该图片无替代文字
  • 查看Mirus Bio的组织主页

    4,959 位关注者

    Meet the Experts Behind AAV Scale-Up Success? Scaling #AAV production isn’t just about increasing volume - it’s about precision, process development, and problem-solving. ?? Sandy Tseng, Ph.D. (Mirus Bio) – A specialist in gene delivery optimization, Sandy works directly with scientists to refine and troubleshoot their #transfection workflows.? ?? Hugh Murray (MilliporeSigma) – A bioprocess development expert, Hugh has helped advance #AAVmanufacturing by integrating DoE methodology, predictive modeling, and scalable platform processes.? ?? Together, they’ll walk you through a 200L bioreactor case study and reveal strategies to overcome common scale-up challenges in a webinar hosted by Cell & Gene Therapy Insights ? ?? Register now to learn from their experience: https://lnkd.in/eUgvtU6v #GeneTherapy #Bioprocessing

    • Avoiding Scale-Up Pitfalls: Upstream process development strategies for AAV manufacturing 
Sandy Tseng, Field Application Scientist  at Mirus Bio 
Hugh Murray, Process Development Senior Scientist at MilliporeSigma

February 26th Wednesday 8:00 PST | 11:00 EST | 16:00 GMT | 17:00 CET
Register to Watch

相似主页

查看职位